Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 13, Issue 12, pp. 3605-3610
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 19, 2007
- Revision received February 28, 2007
- Accepted March 7, 2007
- Published first May 17, 2007.
Copyright & Usage
American Association for Cancer Research
Author Information
- Suresh S. Ramalingam1,3,
- Robert A. Parise3,
- Ramesh K. Ramananthan1,3,
- Theodore F. Lagattuta3,
- Lori A. Musguire1,
- Ronald G. Stoller1,
- Douglas M. Potter4,5,
- Athanassios E. Argiris1,3,
- James A. Zwiebel6,
- Merrill J. Egorin1,2,3, and
- Chandra P. Belani1,3
- Authors' Affiliations:1Division of Hematology-Oncology, Department of Medicine and 2Deparment of Pharmacology, University of Pittsburgh School of Medicine; 3Molecular Therapeutics/Drug Discovery Program and 4Biostatistics Facility, University of Pittsburgh Cancer Institute; 5Biostatistics Department, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania and 6Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland
- Requests for reprints:
Suresh S. Ramalingam, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, MD5150 Centre Avenue, Suite 555, UPMC Cancer Pavilion, Pittsburgh, PA 15232. Phone: 412-648-6619; Fax: 412-648-6579; E-mail: ramalingams{at}upmc.edu.
June 2007
Volume 13, Issue 12
Volume 13, Issue 12
Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies
Jump to section
Advertisement